These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10089858)

  • 1. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
    Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M
    Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICD therapy in survivors of sudden cardiac death awaiting heart transplantation.
    Grimm M; Grimm G; Zuckermann A; Wieselthaler G; Feuerstein M; Daneschvar H; Schmiedinger H; Schreiner W; Wolner E; Laufer G
    Ann Thorac Surg; 1995 Apr; 59(4):916-20. PubMed ID: 7695418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M; Wan C; Singh V; Salehi N; Ahmad J; Szymkiewicz SJ; Thakur RK
    J Heart Lung Transplant; 2015 Oct; 34(10):1305-9. PubMed ID: 26094085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioverter defibrillator therapy as a bridge to heart transplantation.
    Trappe HJ; Wenzlaff P
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 2):622-31. PubMed ID: 7777427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication.
    Saba S; Atiga WL; Barrington W; Ganz LI; Kormos RL; MacGowan GA; Mathier MA; McNamara DM; Obioha-Ngwu O; Murali S
    J Heart Lung Transplant; 2003 Apr; 22(4):411-8. PubMed ID: 12681418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategies in management of heart transplantation candidates with tachycardic ventricular arrhythmia anamnesis].
    Grimm M; Grimm G; Zuckermann A; Wieselthaler G; Daneschvar H; Kocher A; Feuerstein M; Schmidinger H; Podczeck A; Pacher R
    Wien Klin Wochenschr; 1995; 107(16):479-84. PubMed ID: 7571641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of the implantable cardioverter-defibrillator in patients on the waiting list for heart transplantation].
    Podczeck A; Hief C; Jakl G; Frohner K; Nürnberg M; Kaltenbrunner W; Veit F; Laufer G; Steinbach K
    Wien Klin Wochenschr; 1995; 107(16):485-8. PubMed ID: 7571642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.
    Tsai VW; Cooper J; Garan H; Natale A; Ptaszek LM; Ellinor PT; Hickey K; Downey R; Zei P; Hsia H; Wang P; Hunt S; Haddad F; Al-Ahmad A
    Circ Heart Fail; 2009 May; 2(3):197-201. PubMed ID: 19808340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation.
    Grimm M; Wieselthaler G; Avanessian R; Grimm G; Schmidinger H; Schreiner W; Podczeck A; Wolner E; Laufer G
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):532-9. PubMed ID: 7637372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.
    Fonarow GC; Feliciano Z; Boyle NG; Knight L; Woo MA; Moriguchi JD; Laks H; Wiener I
    Am J Cardiol; 2000 Apr; 85(8):981-5. PubMed ID: 10760339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary preventive cardioverter-defibrillator implantation (Pro-ICD) in patients awaiting heart transplantation. A prospective, randomized, controlled 12-year follow-up study.
    Pezawas T; Grimm M; Ristl R; Kivaranovic D; Moser FT; Laufer G; Schmidinger H
    Transpl Int; 2015 Jan; 28(1):34-41. PubMed ID: 25176271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early benefit of implantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation.
    Lorga-Filho A; Geelen P; Vanderheyden M; Malacky T; Primo J; Goethals M; Wellens F; Brugada P
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1747-50. PubMed ID: 9744438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation.
    Saxon LA; Wiener I; DeLurgio DB; Natterson PD; Laks H; Drinkwater DC; Stevenson WG
    Am Heart J; 1995 Sep; 130(3 Pt 1):501-6. PubMed ID: 7661067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator and wait-list outcomes in pediatric patients awaiting heart transplantation.
    El-Assaad I; Al-Kindi SG; Oliveira GH; Boyle GJ; Aziz PF
    Heart Rhythm; 2015 Dec; 12(12):2443-8. PubMed ID: 26247317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.